Background: Transcatheter closure of moderate sized atrial septal defects (ASD) has been demonstrated to be safe and effective. However, the feasibility of transcatheter closure of very large defects is less clear, particularly when an aortic rim of septal tissue is absent.
Introduction

S
ecundum atrial septal defects (ASD) have been closed percutaneously using a transcatheter approach for nearly 40 years [1] . Although surgical and transcatheter closure success rates are comparable, the transcatheter approach, where feasible is now the preferred technique as it is associated with shorter hospitalisation and lower morbidity [2] [3] [4] . Previous studies have demonstrated that transcatheter closure of moderate sized ASDs is safe and effective [5, 6] . However, the feasibility of a transcathe-ter approach for very large defects (>30 mm diameter) is less clear, particularly when a rim of septal tissue at the aortic root is absent and when the postero-inferior rim is deficient (<5 mm). Whilst the European and Canadian congenital heart disease guidelines recommend transcatheter closure for ASDs measuring less than 38 mm diameter, US guidelines do not specify a maximal ASD size that is suitable for transcatheter closure [7] [8] [9] . Indeed few studies have compared success rates and safety for transcatheter closure of moderately large, very large and extremely large ASDs on an intention to treat basis. We therefore report results from a series of patients with moderately large (20-29 mm), very large (30-39 mm) and extremely large (≥40 mm) ASDs who underwent attempted transcatheter closure at a single interventional cardiology centre.
Methods
Patients
The study population consisted of 42 consecutive patients referred to a single large interventional cardiology service for transcatheter closure of a single large ASD, defined as maximal ASD diameter of ≥20 mm but <40 mm on the pre-procedural transoesophageal echocardiogram (TOE). All study patients had demonstrated right heart dilatation and colour Doppler evidence of left to right inter-atrial shunting on pre-procedural transthoracic echocardiography (TTE). Follow up was performed by the referring physician.
Peri-procedural Transthoracic Echocardiography
All patients underwent TTE prior to the ASD closure procedure. Right ventricular size and function was assessed as per ASE guidelines from para-sternal, apical and subcostal views [10] . The right ventricle (RV) was categorised as being mildly, moderately or severely dilated. If tricuspid regurgitation was present, RV systolic pressure was estimated using the Bernoulli equation in combination with right atrial pressure that was estimated from the inferior vena cava size and respiratory variation. All patients had a complete TTE study on the day following the ASD closure procedure.
Transoesophageal Echocardiography
TOE examination was performed with Philips echocardiography machines (5500 or iE33) utilising a multiplane two-dimensional or three-dimensional probe. TOE studies were either performed in the lead up to the procedure or in the cardiac catheterisation laboratory immediately prior to the procedure. Standard mid-oesophageal views were acquired at 0 • , 45 • , 90 • , and 135 • to assess the maximum ASD diameter. All procedures also involved further sizing of the defects with an Amplatzer sizing balloon, which provided a maximal "stretched diameter". The largest diameter obtained at either study was recorded as ASD size.
The anatomical characteristics of ASDs were carefully assessed by a cardiologist experienced in the performance of TOE to document the presence of an aneurysmal septum (defined as total excursion greater than 10 mm) and the presence or absence of a rim of septal tissue at the aortic root, as assessed in the mid-oesophageal short axis (45 • ) view.
Procedural Success and Follow-up
Transcatheter closure was performed using previously described techniques [11] . Procedural success was defined as successful delivery of the closure device with no periprocedural complications, satisfactory appearance of the occluder device at the post-procedure TTE (day one) with no pericardial effusion, and patient discharged from hospital day one post-procedure with no additional medical attention required. Procedural complications were defined as bleeding requiring transfusion, advanced heart block requiring cardiac pacing, or abnormalities on the post-procedure TTE including pericardial effusion, new or 
Statistical Analysis
Descriptive statistics described population mean, median, and standard deviation. ASDs were further analysed according to size [moderately large (20-29 mm), very large (30-39 mm) and extremely large (≥40 mm)] defined as the largest diameter obtained at either the pre-procedural TOE or the intra-procedural TOE during balloon sizing of the defect ("stretched diameter"), and the presence or absence of an aortic rim of septal tissue. Group comparisons were made with the student t-test. A p value < 0.05 was considered statistically significant.
Results
Patient Characteristics
Baseline characteristics of the 42 patients with large ASD are presented in Table 1 . The majority of patients were female (76%) with a mean age of 40 ± 18 years. The population was relatively healthy with only four out of the 42 patients having co-morbidities (hypertension). All patients had normal left ventricular size and ejection fraction. Right ventricular size was at least mildly dilated in all patients with 19% of patients having a severely dilated RV. Right ventricular systolic function was normal in 40% of patients; only one of the 42 patients had severely reduced RV ejection fraction.
ASD Characteristics
ASD characteristics are presented in Table 2 . As expected, ASD diameter at the initial TOE was smaller than the "stretched diameter" obtained following intra-procedural 
Procedural Results
Procedural outcomes are presented in Table 3 Procedure failure occurred in six patients (14%), five of whom had extremely large defects (mean diameter 41.3 ± 1.6 mm) ( Table 4 ). The remaining patient had a very large defect (34 mm). Deployment of the device in this patient resulted in impingement of the left atrial disc on the anterior mitral valve leaflet. The device was therefore not released. Of the five failures in those with extremely large ASDs, four had deficient postero-inferior septal rims. In two of the four it was judged inappropriate to proceed with device delivery after the inflated balloon repeatedly slipped into the right atrium. Of the remaining two patients with deficient postero-inferior rims, in one the partially deployed device was deemed too unstable to be released; in the other the device was apparently successfully deployed but subsequently was found free in the right atrium on the routine TTE the next day. The patient remained asymptomatic throughout; the device was removed at open heart surgery that day and the ASD closed uneventfully. In remaining patient, the left atrial disc impinged on the anterior mitral valve leaflet and a decision was made not to release the device. Thus of the six failures only one patient left the cardiac catheterisation suite with the device in situ. All six patients with failed deployment subsequently underwent successful surgical closure of the ASD; five on an elective basis.
There were no late complications related to the device documented on clinical follow up ranging from six months to 13 years (median 10 months). All patients had at least one follow up TTE at least three months or greater after the procedure and no patient had a significant residual shunt.
Discussion
The study demonstrates that the vast majority (97%) of large ASDs, defined as maximal ASD diameter in the range 20-39 mm, can be closed with transcatheter techniques with a very low complication rate. However, attempts at transcatheter closure of extremely large defects (≥40 mm) are associated with a low success rate and the potential for complications.
For ASD patients with clinical indications for defect closure, a transcatheter approach, if feasible, is preferable to open heart surgery. Commercially available closure devices are designed to occlude ASDs up to a maximal diameter of 40 mm however the overhang of the left atrial disc (8 mm) and the right atrial disc (6 mm) raises the possibility that some ASDs >40 mm could be successfully closed as was the case in one patient in our series. The challenge presented by ASDs requiring very large devices is the capacity of the left atrium to accommodate the device without interfering with other cardiac structures such as the anterior leaflet of the mitral valve, and device stability after deployment.
There is no universally accepted definition for large ASDs. Studies have variously described the lower cut-off levels for large ASDs in the diameter range 20-30 mm and an upper cut-off level of between 36 and 40 mm [5,6,12,13]. As such, direct comparison with other studies is difficult particularly as some studies report outcomes only in terms of devices that were actually deployed and released at the time of catheterisation and do not mention cases where no attempt was made to deploy a device after balloon sizing or cases where a device was deployed but not released either because of device instability or device Heart, Lung and Circulation Transcatheter Closure of Secundum Atrial Septal Defects 2013;xxx:1-5 Table 3 . Procedural success in all patients and according to ASD size. and Rodriguez et al. [12] . In contrast, the success rate in those with extremely large ASDs (≥40 mm) was poor (17%) indicating that such defects are generally not suitable for transcatheter closure. Five of the six failures and the only complication in our series occurred in those with extremely large ASDs (≥40 mm). Four of those five had deficient postero-inferior rims -an anatomical finding well known to be associated both with difficulty in obtaining a stable position of the device and a high risk of device embolism [14] [15] [16] [17] . Based on our experience we now no longer attempt closure of ASDs ≥40 mm in diameter. This recommendation is in compliance with the current "instructions for use" guidelines for both the Amplatzer and the Occlutech devices.
Large ASDs are often associated with deficient aortic rims. A deficient aortic rim has been proposed by some to be a relative contraindication to transcatheter closure [18] . Others have demonstrated that in experienced hands such deficiency does not materially affect success or complication rates, however the absence of an aortic rim does make the procedure more challenging [4, 11, 18, 19] . In our series the presence or absence of an aortic rim did not influence the results. As such we do not regard an absent aortic rim as a contra-indication to percutaneous closure. Limitations of our study were that it was conducted retrospectively, the numbers were relatively small and not all patients had long term follow up TTE beyond three months following the procedure. Nevertheless clinical follow up has been complete and we think it unlikely that we have missed any very late device related complications such as device embolism or cardiac perforation.
In conclusion, our study has demonstrated that percutaneous closure of large ASDs in the range of 20-39 mm diameter can be safely performed with high success rates. In contrast the success rate for ASDs ≥40 mm in diameter is low and such patients are more appropriately considered as surgical candidates.
